Bringing new drugs to market is an expensive and time-consuming endeavor. Today, NVIDIA joined forces with several leading pharmaceutical organizations including Amgen, Bayer, Boehringer Ingelheim, GSK, Janssen Pharmaceutica NV of Johnson & Johnson, Merck, and Novartis, and several others, to tackle this problem.

The post NVIDIA and World’s Top Pharmaceuticals Team to Bring AI to Drug Discovery appeared first on NVIDIA Developer News Center.